Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triple negative breast cancer in Asia: An insider's view.
Wang C, Kar S, Lai X, Cai W, Arfuso F, Sethi G, Lobie PE, Goh BC, Lim LHK, Hartman M, Chan CW, Lee SC, Tan SH, Kumar AP. Wang C, et al. Among authors: kar s. Cancer Treat Rev. 2018 Jan;62:29-38. doi: 10.1016/j.ctrv.2017.10.014. Epub 2017 Nov 10. Cancer Treat Rev. 2018. PMID: 29154023 Review.
PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
Chen L, Yuan Y, Kar S, Kanchi MM, Arora S, Kim JE, Koh PF, Yousef E, Samy RP, Shanmugam MK, Tan TZ, Shin SW, Arfuso F, Shen HM, Yang H, Goh BC, Park JI, Gaboury L, Lobie PE, Sethi G, Lim LHK, Kumar AP. Chen L, et al. Among authors: kar s. Mol Cancer Ther. 2017 Nov;16(11):2528-2542. doi: 10.1158/1535-7163.MCT-16-0739. Epub 2017 Aug 15. Mol Cancer Ther. 2017. PMID: 29021293
Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner.
Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, Tulsian NK, Gruber JJ, DiMascio L, Paszkiewicz KH, Ingram PJ, D Boyd-Kirkup J. Thakkar D, et al. Among authors: kar s. J Immunother Cancer. 2022 Feb;10(2):e003382. doi: 10.1136/jitc-2021-003382. J Immunother Cancer. 2022. PMID: 35131861 Free PMC article.
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry (Part 1A - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV).
Wojcik J, Sikorski T, Wang J, Huang Y, Sugimoto H, Baratta M, Ciccimaro E, Green R, Jian W, Kar S, Kim YJ, Lassman M, Mohapatra S, Qian M, Rosenbaum AI, Sarvaiya H, Tian Y, Vainshtein I, Yuan L, Tao L, Ji A, Kochansky C, Qiu H, Maes E, Chen LZ, Cooley M, Dufield D, Hyer E, Johnson J, Li W, Liu A, Lu Y, Meissen J, Palandra J, Tang X, Vigil A, Wei W, Vinter S, Xue Y, Yang L, Zheng N, Benson K, McCush F, Liang Z, Abberley L, Andisik M, Araya M, Cho SJ, Colligan L, Dasgupta A, Dudek M, Edmison A, Fischer S, Folian B, Garofolo F, Ishii-Watabe A, Ivanova D, Gijsel SK, Luo L, McGuinness M, 'Day CO, Salehzadeh-Asl R, Neto JT, Verhaeghe T, Wan K, Whale E, Yan W, Yang E, Zhang J. Wojcik J, et al. Among authors: kar s. Bioanalysis. 2025 Jan 25:1-39. doi: 10.1080/17576180.2025.2450194. Online ahead of print. Bioanalysis. 2025. PMID: 39862144
2,657 results